tiprankstipranks
Albemarle (NYSE:ALB) Slides as Wall Street Grows Cautious
Market News

Albemarle (NYSE:ALB) Slides as Wall Street Grows Cautious

Story Highlights

Albemarle shares fell amid cautious outlooks from several analysts.

Shares of chemicals manufacturing company Albemarle (NYSE:ALB) fell more than 7% in Monday’s trading session as Wall Street analysts grew cautious of the stock, thus pushing investors to the sidelines. 

Don't Miss our Black Friday Offers:

Notably, Joshua Spector, an analyst at investment firm UBS, downgraded ALB to Neutral from Buy on weakening lithium prices and a weak electric vehicle outlook. He also cut his price target to $140 from $253. Spector noted that the firm’s electric vehicle team predicted decreased EV growth due to poorer demand expectations in the United States and Europe

Similarly, Morgan Stanley analyst Vincent Andrews sees downside potential in lithium and lithium stock prices in the near-to-medium term. According to Andrews, the risks will deepen as demand for lithium and electric vehicles slump.

Furthermore, Arun Viswanathan of RBC Capital lowered his price target for Albemarle to $163 from $212. However, he kept his Outperform rating due to the company’s strong financial position, low inventory levels, and long-term growth prospects.

So far, ALB shares have declined by 44% this year. Furthermore, the recent selloff erased any price gains the stock mustered over the past five days. 

Is ALB Stock a Good Buy?

Turning to Wall Street, analysts have a Moderate Buy consensus rating on ALB stock based on eight Buys, two Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average ALB price target of $202.27 per share implies 70.15% upside potential.

Disclosure

Related Articles
TheFlyEarly notable gainers among liquid option names on November 19th
TheFlyEarly notable gainers among liquid option names on November 13th
TheFlyAlbemarle price target raised to $133 from $108 at RBC Capital
Go Ad-Free with Our App